Skip to main content

The Group

Co-Chairs

Harvey V. Fineberg
President, Gordon and Betty Moore Foundation

Shirley M. Tilghman
President of the University, Emeritus, and Professor Emeritus of Molecular Biology and Public Affairs, Princeton University

Members

Ann Arvin
Lucile Salter Packard Professor of Pediatrics and Professor of Microbiology and Immunology, Stanford University School of Medicine; Vice Provost and Dean of Research Emeritus, Stanford University

Seth Berkley
Chief Executive Officer, Gavi, the Vaccine Alliance

Alan Bernstein
President and Chief Executive Officer, CIFAR

Tanisha Carino
Executive Vice President and Chief Corporate Affairs Officer, Alexion

Michael Conway
Senior Partner, McKinsey & Company

Kathryn Edwards
Sarah H. Sell and Cornelius Vanderbilt Chair in
Pediatrics and Professor of Pediatrics, Vanderbilt School of Medicine

Mark Feinberg
President and Chief Executive Officer, International AIDS Vaccine Initiative (IAVI)

Katherine O’Brien
Director, Department of Immunization, Vaccines and Biologicals, World Health Organization (WHO)

Muhammad Pate
Global Director, Health, Nutrition and Population (HNP) Global Practice, World Bank; Director, Global Financing Facility for Women, Children and Adolescents (GFF)

Helen Rees
Founder and Executive Director, Wits Reproductive Health and HIV Institute, University of Witwatersrand

Laura Riley
Obstetrician and Gynecologist-in-Chief, New York-Presbyterian /Weill Cornell Medical Center; Chair, Department of Obstetrics and Gynecology, Weill Cornell Medicine

Margaret Hamburg
Foreign Secretary, National Academy of Medicine; Chair of the Board, American Association for the Advancement of Science (AAAS)

Penny Heaton
Chief Executive Officer, Bill & Melinda Gates Medical Research Institute

Richard Klausner
Founder and Chief Executive Officer, Lyell Immunopharma

Simon Levin
James S. McDonnell Distinguished University, Professor in Ecology and Evolutionary Biology, Princeton University; Director, Center for BioComplexity, Princeton, Environmental Institute, Princeton University

Diego Miralles
Chief Executive Officer, Vividion Therapeutics

Kelly Moore
Associate Director of Immunization Education, Immunization Action Coalition; Adjunct Associate Professor, Health Policy, Vanderbilt University Medical Center

Pardis Sabeti
Professor, Center for Systems Biology and Department of Organismic and Evolutionary Biology, Harvard University; Department of Immunology and Infectious Disease, Harvard T.H. Chan School of Public Health; Broad Institute of Harvard and MIT

George Siber
Director and Co-founder, Affinivax; Adjunct Professor of Medicine, Johns Hopkins Medical School

Michael Specter
Staff Writer, The New Yorker

Wendy Taylor
Vice President, Technical Leadership and Innovation, Jhpiego

Robert Tepper
Co-Founder and General Partner, Third Rock Ventures, LLC

Project Staff

Bruce Gellin
President, Global Immunization, Sabin Vaccine Institute

Jamie Minchin
Senior Associate, Vaccine Acceptance & Demand, Sabin Vaccine Institute

Brittany Hackett
Senior Manager, Communications, Vaccine Acceptance & Demand Sabin Vaccine Institute

Ruth Katz
Vice President and Executive Director, Health, Medicine and Society Program, The Aspen Institute

Katya Wanzer
Senior Program Associate Health, Medicine and Society Program, The Aspen Institute

Jonathan Purves
Senior Media Relations Manager, The Aspen Institute

Special Thanks

Arthur Allen
Editor, California Healthline, Kaiser Health News

Michael Watson
Chief Executive Officer, VaxEquity

Karyn Feiden
Contributing Writer

Next

Foreword

Start reading